INTERSTIM II
Report
- Report Number
- 3007566237-2016-03274
- Event Type
- Injury
- Date Received
- September 15, 2016
- Date of Event
- June 13, 2016
- Report Date
- September 15, 2016
- Manufacturer
- MEDTRONIC NEUROMODULATION
- Product Code
- EZW
- PMA / PMN Number
- P080025
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NL
- Reporter Occupation
- PHYSICIAN
Narratives
DATE OF EVENT: PLEASE NOTE THAT THIS DATE IS BASED OFF OF THE DATE OF PUBLICATION OF THE ARTICLE AS THE EVENT DATES WERE NOT PROVIDED IN THE PUBLISHED LITERATURE. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED EVENTS. THE DEVICE WAS USED FOR AN OFF LABEL INDICATION; CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID 3889, PRODUCT TYPE: LEAD. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
VAN DER WILT, A.A., VAN WUNNIK, B.P., STURKENBOOM, R., HAN-GEURTS, I.J., MELENHORST, J., BENNINGA, M.A., BAETEN, C.G.M.I., BREUKINK, S.O. SACRAL NEUROMODULATION IN CHILDREN AND ADOLESCENTS WITH CHRONIC CONSTIPATION REFRACTORY TO CONSERVATIVE TREATMENT. INT. J. COLORECTAL DIS. 2016. 31(8):1459-1466. DOI 10.1007/S00384-016-2604-8. SUMMARY: THE AIM OF THIS STUDY WAS TO EVALUATE WHETHER THE SHORT-TERM EFFECTS OF SACRAL NEUROMODULATION (SNM) IN CHILDREN AND ADOLESCENTS WITH CONSTIPATION ARE SUSTAINED OVER PROLONGED PERIOD OF TIME. REPORTED EVENTS: PATIENT 11: A (B)(6) FEMALE PATIENT WITH SACRAL NEUROMODULATION (SNM) FOR REFRACTORY CONSTIPATION HAD THEIR ELECTRODE REMOVED WITHIN A YEAR POST-IMPLANT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 605573 | INTERSTIM II | STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE | EZW | MEDTRONIC NEUROMODULATION | 3058 | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 14 YR | Required Intervention |